When inspecting the intravenous site of a patient receiving a vesicant chemotherapy agent, the LPN notes a small area of swelling. What should the LPN do first?

Question

Quizplus · Accepted Answer

Swelling at the intravenous site of a patient receiving a vesicant chemotherapy agent could indicate extravasation, which is the leakage of the chemotherapy agent into the surrounding tissues. This can cause tissue damage and necrosis. Therefore, the LPN should discontinue the infusion and notify the RN to assess the site and determine appropriate interventions. Documenting the finding in the chart and checking the site every hour may also be necessary, but these actions should not delay discontinuing the infusion and notifying the RN. No action is needed is not the correct answer as extravasation is a serious situation that requires action.

When Inspecting the Intravenous Site of a Patient Receiving a Vesicant